Clinical trials
Alzheimer Disease trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Recruiting | 10 |
| Terminated | 9 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| H. Lundbeck A/S | 5 |
| Bristol-Myers Squibb | 3 |
| Hoffmann-La Roche | 3 |
| Pfizer | 3 |
| Affiris AG | 2 |
| Alzheon Inc. | 2 |
| AstraZeneca | 2 |
| Axovant Sciences Ltd. | 2 |
| FORUM Pharmaceuticals Inc | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 63 |
| Dementia | 18 |
| Cognitive Dysfunction | 11 |
| Brain Diseases | 4 |
| Mental Disorders | 4 |
| Nervous System Diseases | 4 |
| Neurodegenerative Diseases | 4 |
| Tauopathies | 4 |
| Amyloid Neuropathies, Familial | 3 |
| Amyloidosis | 3 |
Trials
Showing 26 to 50 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.